Crystal structure of (E)-N-(2-bromophenyl)-4-(4-(3,5-dimethoxystyryl)phenoxy)pyrimidin-2-amine, C26H22BrN3O3-Reference-Cited by-同舟云学术

Crystal structure of (E)-N-(2-bromophenyl)-4-(4-(3,5-dimethoxystyryl)phenoxy)pyrimidin-2-amine, C₂₆H₂₂BrN₃O₃

Published:2024-06-20 Issue:4 Volume:239 Page:763-765
ISSN:1433-7266
Container-title:Zeitschrift für Kristallographie - New Crystal Structures
language:en
Short-container-title:

Author:

Sun Wuji¹²^ORCID,Sun Lixin²,Yan Hong¹

Affiliation:

1. College of Chemistry and Life Science, Beijing University of Technology , 100124 Beijing , P.R. China

2. China Resources Sanjiu (Tangshan) Pharmaceutical Co., Ltd., High Technology Development Zone , 063009 Tangshan , P.R. China

Abstract

Abstract C26H22BrN3O3, monoclinic, P21/c (no. 14), a = 17.7467(15) Å, b = 10.7974(8) Å, c = 11.9136(8) Å, β = 96.084°, V = 2270.0(3) Å3, Z = 4, Rgt (F) = 0.0375, wRref (F 2) = 0.1205, T = 293 K.

Publisher

Walter de Gruyter GmbH

Link

https://www.degruyter.com/document/doi/10.1515/ncrs-2024-0187/pdf

Reference11 articles.

1. BRUKER. SAINT. Version 8.23B; Bruker AXS Inc.: Madison, Wisconsin, USA, 2013.

2. Sheldrick, G. M. Crystal Structure Refinement with SHELX. Acta Crystallogr. 2015, C71, 3–8.

3. Sheldrick, G. M. A Short History of SHELX. Acta Crystallogr. 2008, A64, 112–122, https://doi.org/10.1107/s0108767307043930.

4. Estrela, J. M.; Ortega, A.; Mena, S.; Rodriguez, M. L.; Asensi, M. Pterostilbene Biomedical Applications. Crit. Rev. Clin. Lab. Sci. 2013, 50, 65–78; https://doi.org/10.3109/10408363.2013.805182.

5. Riche, D. M.; McEwen, C. L.; Riche, K. D.; Sherman, J. J.; Wofford, M. R.; Deschamp, D.; Griswold, M. Analysis of Safety from a Human Clinical Trial with Pterostilbene. J. Toxicol. 2013, 2013, 463595; https://doi.org/10.1155/2013/463595.